Effect of anti-sclerostin antibody on orthodontic tooth movement in ovariectomized rats
Author Information
Author(s): Hyunna Ahn, Wonse Park, Sung-Hwan Choi, Namki Hong, Jisun Huh, Seoyeon Jung
Primary Institution: Yonsei University College of Dentistry, Seoul, Korea
Hypothesis
Anti-Scl Ab, by modulating the expression of RANKL, OPG, and sclerostin, would initially increase OTM, and subsequently decrease it.
Conclusion
Romosozumab initially accelerated tooth movements, but later decreased tooth movement.
Supporting Evidence
- The ROMO group showed more tooth movement on day 7 of orthodontic treatment.
- On days 10 and 14, relatively less movement was observed in the ROMO group.
- The OPG/RANKL ratio showed significant differences in expression between the two groups.
Takeaway
This study looked at how a special medicine affects tooth movement in rats that had their ovaries removed. At first, the medicine helped the teeth move faster, but then it slowed them down.
Methodology
Twenty-four 12-week-old female Sprague-Dawley rats were divided into two groups: OVX and ROMO. OTM was performed 8 weeks after OVX, with the ROMO group receiving romosozumab injections.
Limitations
The study did not include a comparison with normal rats or a male cohort.
Participant Demographics
Twenty-four 12-week-old female Sprague-Dawley rats.
Statistical Information
P-Value
p=0.009
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website